Additional inhibitor can help anti-VEGF therapy overcome resistance in deadly brain cancer
Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.